Arvee Laboratories (India) Ltd. | Small-cap | Basic Materials
₹169.39
-0.33%
| Arvee Laboratories Stock Comparison:
Arvee Laboratories vs Asian PaintsArvee Laboratories vs Pidilite IndustriesArvee Laboratories vs Balaji AminesArvee Laboratories vs Kingfa ScienceArvee Laboratories vs Grauer & WeilArvee Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2024

Income Metrics

Revenue 89.1M
Gross Profit 36.7M 41.17%
Operating Income 729.0K 0.82%
Net Income 1.5M 1.74%
EPS (Diluted) ₹0.14

Balance Sheet Metrics

Total Assets 400.5M
Total Liabilities 90.1M
Shareholders Equity 310.4M
Debt to Equity 0.29

Cash Flow Metrics

Revenue & Profitability Trend

Arvee Laboratories Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i303.4M612.8M396.9M471.4M448.4M
Cost of Goods Sold i187.6M439.7M258.8M328.4M323.8M
Gross Profit i115.8M173.1M138.1M143.0M124.6M
Gross Margin % i38.2%28.2%34.8%30.3%27.8%
Operating Expenses
Research & Development i--00-
Selling, General & Administrative i22.7M35.3M26.7M25.5M40.8M
Other Operating Expenses i108.4K78.5K510.4K490.3K52.9K
Total Operating Expenses i22.9M35.4M27.2M26.0M40.8M
Operating Income i14.9M52.4M30.0M38.1M38.4M
Operating Margin % i4.9%8.6%7.6%8.1%8.6%
Non-Operating Items
Interest Income i3.6M2.0M2.7M2.8M1.4M
Interest Expense i1.9M2.9M3.1M4.9M8.9M
Other Non-Operating Income-----
Pre-tax Income i18.3M61.7M34.5M36.4M30.9M
Income Tax i7.8M20.5M8.8M9.6M7.9M
Effective Tax Rate % i42.5%33.2%25.4%26.5%25.6%
Net Income i10.5M41.2M25.7M26.8M23.0M
Net Margin % i3.5%6.7%6.5%5.7%5.1%
Key Metrics
EBITDA i34.4M85.6M59.7M64.7M62.3M
EPS (Basic) i₹0.95₹3.74₹2.34₹3.24₹2.09
EPS (Diluted) i₹0.95₹3.74₹2.34₹3.24₹2.09
Basic Shares Outstanding i110200001102000011020000852400011020000
Diluted Shares Outstanding i110200001102000011020000852400011020000

Income Statement Trend

Arvee Laboratories Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i18.5M5.4M12.8M66.1M9.8M
Short-term Investments i154.3K3.5M18.2M20.3M30.9M
Accounts Receivable i61.1M122.6M121.3M78.8M65.2M
Inventory i64.0M45.7M57.3M74.3M64.7M
Other Current Assets26.5M-101-
Total Current Assets i167.9M215.7M221.6M255.5M178.4M
Non-Current Assets
Property, Plant & Equipment i14.7M9.1M9.1M9.0M8.1M
Goodwill i22.5K101.5K187.0K272.5K358.0K
Intangible Assets i22.5K101.5K187.0K272.5K358.0K
Long-term Investments-----
Other Non-Current Assets12.5K25.0K37.5K652.1K1.3M
Total Non-Current Assets i214.1M171.2M165.2M154.9M157.8M
Total Assets i382.0M386.9M386.8M410.5M336.2M
Liabilities
Current Liabilities
Accounts Payable i66.2M79.2M98.4M95.4M100.4M
Short-term Debt i0021.3M78.8M19.1M
Current Portion of Long-term Debt-----
Other Current Liabilities-10-10-1030.0K
Total Current Liabilities i69.4M88.4M132.9M182.9M124.9M
Non-Current Liabilities
Long-term Debt i10.0M10.0M10.0M10.0M19.6M
Deferred Tax Liabilities i8.4M5.0M2.0M3.1M4.2M
Other Non-Current Liabilities10-1.0K-1.0K-
Total Non-Current Liabilities i21.4M17.8M14.5M13.1M23.8M
Total Liabilities i90.8M106.2M147.4M196.1M148.6M
Equity
Common Stock i110.2M110.2M110.2M110.2M55.1M
Retained Earnings i161.6M151.1M109.9M84.8M58.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i291.1M280.6M239.4M214.4M187.6M
Key Metrics
Total Debt i10.0M10.0M31.3M88.8M38.7M
Working Capital i98.5M127.3M88.7M72.6M53.6M

Balance Sheet Composition

Arvee Laboratories Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i18.3M61.7M34.5M36.4M30.9M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i29.4M-13.6M-50.1M-31.0M19.3M
Operating Cash Flow i46.0M48.9M-15.1M7.5M57.8M
Investing Activities
Capital Expenditures i-25.9M-14.7M-23.6M-22.4M-22.9M
Acquisitions i-----
Investment Purchases i00---11.4M
Investment Sales i644.8K83.3K21.6M13.6M2.1M
Investing Cash Flow i-24.6M-14.5M-2.1M-8.9M-32.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i---50.1M-
Debt Repayment i--21.3M-57.5M0-75.2M
Financing Cash Flow i0-42.6M-115.0M100.2M-150.4M
Free Cash Flow i10.8M14.4M-16.8M-5.8M80.3M
Net Change in Cash i21.5M-8.2M-132.2M98.9M-124.9M

Cash Flow Trend

Arvee Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 85.55
Price to Book 6.25
Price to Sales 5.27
PEG Ratio -2.35

Profitability Ratios

Profit Margin 3.88%
Operating Margin 2.84%
Return on Equity 3.61%
Return on Assets 2.75%

Financial Health

Current Ratio 3.49
Debt to Equity 3.31

Per Share Data

EPS (TTM) ₹1.98
Book Value per Share ₹27.11
Revenue per Share ₹32.03

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
arvee1.9B85.556.253.61%3.88%3.31
Asian Paints 2.4T67.5812.5018.28%10.63%11.42
Pidilite Industries 1.6T71.9716.0920.85%16.16%4.56
Balaji Amines 50.2B33.002.727.80%11.11%0.55
Kingfa Science 46.2B30.126.3520.98%8.58%5.90
Grauer & Weil 42.1B26.734.4816.73%13.35%1.26

Financial data is updated regularly. All figures are in the company's reporting currency.